Hospitals & Providers

Study: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.

Two University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.

A Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.

New findings reveal this genetic test to assess breast cancer risk could be more effective than others.

A Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.

A new Commonwealth Fund survey on how Medicaid changes could affect this population, has experts weighing in on ways to resolve the healthcare disconnect.

To date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.

National survey and surveys in New York State, Florida, Texas, and New Hampshire point to a need for more actionable price information.

Nationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project.

A new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.

This novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.

The call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era.

Blue Cross Blue Shield of Illinois partners with gastroenterology group to focus on Crohn’s disease patients.

With a growing need for services, nearly nine in 10 employers cite behavioral health as an important priority in Willis Towers Watson survey.

Two studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help.

The healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.

The healthcare industry continues to focus efforts on treatments that work better, and ideally are less expensive and less invasive for patients.

Getting diabetic patients to adhere to medication and dietary changes can be difficult. Here are some tips from experts.

These trends emerge from CDW’s Patient Engagement Perspective Study, but surprisingly one tech trend didn’t make the cut.

What exactly did House representatives on both sides of the aisle dislike about the AHCA? Here’s a look at what MCOs should know.

Chief experience officers improve the patient experience-and the experience of caregivers.

From a healthcare perspective, bariatric surgery is considered one of the most effective options for short-term and sustained weight loss. But does the investment pay off?

Patient risk can improve value-based cancer care. Find out how.

A study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States.

Here are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions.